Reply
Myung Ji Goh, Seonwoo Kim, Sook Young Woo, Dong Hyun Sinn – 20 December 2019
Soluble Urokinase Receptor and Liver Disease
Changli Wei, Ke Zhu, Jochen Reiser – 20 December 2019
Letter to the Editor: Might Denosumab Fit in Primary Biliary Cholangitis Treatment?
Ana Lleo, Xiong Ma, M. Eric Gershwin, Pietro Invernizzi – 20 December 2019
An Update on Machine Preservation of the Liver
Garrett R. Roll – 20 December 2019
Liver Transplantation Using Steatotic Grafts
Kyle R. Jackson, Jane Long, Benjamin Philosophe, Jacqueline Garonzik‐Wang – 20 December 2019
A Practical Approach to Polycystic Liver Disease
Armani Patel, Arlene B. Chapman, Adam E. Mikolajczyk – 20 December 2019
Multidisciplinary Care for Cystic Fibrosis Liver Disease: Where Does the Adult Hepatologist Fit In?
Fares Ayoub, Hechu Li, Charles Blay, Cesar Trillo‐Alvarez, Jorge Lascano, Giuseppe Morelli – 20 December 2019
MRP3‐Mediated Chemoresistance in Cholangiocarcinoma: Target for Chemosensitization Through Restoring SOX17 Expression
Elisa Lozano, Maitane Asensio, Laura Perez‐Silva, Jesus M. Banales, Oscar Briz, Jose J.G. Marin – 20 December 2019
Focal Adhesion Kinase Promotes Hepatic Stellate Cell Activation by Regulating Plasma Membrane Localization of TGFβ Receptor 2
Yunru Chen, Qing Li, Kangsheng Tu, Yuanguo Wang, Xianghu Wang, Dandan Liu, Chen Chen, Donglian Liu, Rendong Yang, Wei Qiu, Ningling Kang – 20 December 2019 – Transforming growth factor β (TGFβ) induces hepatic stellate cell (HSC) differentiation into tumor‐promoting myofibroblast, although underlying mechanism remains incompletely understood. Focal adhesion kinase (FAK) is activated in response to TGFβ stimulation, so it transmits TGFβ stimulus to extracellular signal‐regulated kinase and P38 mitogen‐activated protein kinase signaling.
Thrombocytopenia in Cirrhosis: A Review of Pathophysiology and Management Options
Andrew H. Moore – 20 December 2019